2nd Annual MarketsandMarkets

Cell-Gene therapy Bioprocessing Online Conference( Time Zone - EASTERN STANDARD TIME (EST)

June 25 - 26, 2020

30+

Speaker

10+

Networking Hours

150+

Attendees

Virtual engaging model to exact solutions for robust manufacturing and bioprocessing challenges

Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. In our conference of 2017, we assessed the specific risks and benefits of the cell culture and cell therapy bio-manufacturing for the cure of these diseases.

There are still factors like manufacturing maze, investment, logistics and regulatory challenges that prevent the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 2nd Annual MarketsandMarkets Cell & Gene Therapy Bioprocessing Online Conference. Learn from the leading experts of the industry about strategies, technologies, and innovations in the area of bioprocessing of cell-gene therapies.

Due to growing concerns about COVID-19, the event is going fully virtual this year. We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 25th & 26th June 2020. Please write to [email protected] for questions regarding speaking, attending and sponsoring. We will keep you posted with the event flow soon. Keep checking our website.

WHAT TO EXPECT

  • Bioprocessing of 3D cell culture
  • CHO cell lines bioprocessing
  • Automation of cellular therapies
  • AAV vector production
  • Process development and monitoring of cell-gene therapies
  • Optimization of cell-gene therapies
  • Supply chain and reimbursement issues
  • Regulatory guidelines cell and gene-based medicines

  • Learn the latest advancement and opportunities in the area of manufacturing of cell-gene therapies
  • Gain insights in the area of the automated and most effective manufacturing processes
  • Network with the key professionals addressing the strategies of supply chain and regulatory hurdles

From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:

Engineers/ Scientists/ Researchers/ Project leaders in:

  • Bioprocess development
  • Process development
  • GMP/Manufacturing
  • Cellular Therapy
  • Gene Therapy
  • Quality Control
  • Cell Engineering
  • Regulatory affairs

CONFERENCE AGENDA

Opening remarks by Chairperson

Tiffany Rau

Tiffany Rau, Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals

08:55 - 09:00

CELL THERAPY BIOPROCESSING AND DEVELOPMENT

Accelerating process and product development using DoE and predictive modelling

Tiffany Rau

Tiffany Rau, Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals

09:00 - 09:35

Next-generation immunogene therapies: Precision manufacturing for enhanced impact

Jan Joseph Melenhorst

Jan Joseph Melenhorst, Adjunct Associate Professor, Upenn

09:35 - 10:10

The use of capillary electrophoresis in gene therapy product testing

Steve Lock

Steve Lock, Marketing & Marketing Development Manager , SCIEX

10:10 - 10:40

Translating Tissue Engineered Medical Product from laboratory to clinic

Sarindr Bhumiratana

Sarindr Bhumiratana , Chief Scientific Officer , Epibone

10:40 - 11:10

Simple and effective methods for purification and determination of molecular weight of DMT-on and DMT-off oligonucleotides

Bill Evans

Bill Evans, Process Chromatography Technical Specialist , Tosoh Bioscience LLC

11:10 - 11:40

One on One Networking

11:40 - 11:50

Effectively securing cell and gene therapies with closed systems

Jayanthi Grebin

Jayanthi Grebin, Senior Business Development Manager, Cell & Gene Therapy , CPC

11:50 - 12:10

Cytokines and growth factors: Why should you give a HEK

Fiona Bellot

Fiona Bellot, Protein Sales Manager, Proteintech

12:10 - 12:30

PROCESS MONITORING & QUALITY CONTROL

Process development of antigen-specific T cells

Patrick J. Hanley

Patrick J. Hanley, Director of GMP for Immunotherapy, The Children’s Research Institute

12:30 - 13:05

Magic on ice: Next generation DMSO-free biopreservation for cell manufacturing and processing

Xiaoxi Wei

Xiaoxi Wei, Founder & CEO, X-Therma Inc.

13:05 - 13:40

Manufacturing Stem Cell derived products and solving the immune issue

Mahendra Rao

Mahendra Rao, Chief Executive Officer, panCella

13:40 - 14:15

One on One Meeting & Networking

14:15 - 15:00

End of Day 1

15:00 - 15:00

Opening remarks by Chairperson

Janet Rothberg

Janet Rothberg, Development Manager, CCRM

09:15 - 09:20

Importance of identifying critical materials

Dominic Clarke

Dominic Clarke, Global Head Cell Therapy, Strategy and Innovation, , Charles River Laboratories

09:20 - 09:55

Panel Discussion: Autologous vs Allogenic

09:55 - 10:30

Control Potential viral contaminants in biologics with effective testing

Margaret Temple

Margaret Temple, Business Development Manager, SGS

10:30 - 11:00

Scalable lentiviral vector manufacture - The transition from transient to stable systems

Gavin Allsop

Gavin Allsop, Senior Business Development Manager, OXGENE

11:00 - 11:30

Upstream Process Development in stem cell manufacturing

Janet Rothberg

Janet Rothberg, Development Manager, CCRM

11:30 - 12:05

One on One Networking

12:05 - 12:15

Process development and monitoring of cell-gene therapies

Don Healey

Don Healey, SVP Operations and Site Head, KBI Pharma

12:15 - 12:50

LOGISTICS, REGULATORY & INVESTMENT

Building a leading-edge supply chain, while maintaining flexibility

Devyn Smith

Devyn Smith, Chief Executive Officer, Arbor Biotechnologies

12:50 - 13:20

FDA guidelines for regulatory issues involved cell therapy manufacturing

Scott Burger

Scott Burger, Principal, Advanced Cell & Gene Therapy LLC

13:20 - 13:55

Determinants of durable response upon treatment with Axi-Cel

John Rossi

John Rossi, Vice President, Head, Translational Medicine, , Syncopation Lifesciences

13:55 - 14:30

End of Conference

14:30 - 14:30

CONFERENCE SPEAKERS

ADVISORS

Tiffany Rau

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals

Shon Green

Shon Green

Director, Clinical Translation, Altius Institute for Biomedical Sciences

Scott Burger

Scott Burger

Principal, Advanced Cell & Gene Therapy LLC

Geoffrey Hodge

Geoffrey Hodge

Chief Technical Officer , Unum Therapeutics

SPEAKERS

Shailendra Singh (Shelly)

Shailendra Singh (Shelly)

Board Member, MarketsandMarkets

Tiffany Rau

Tiffany Rau

Global Leader in Process Development (R &D, CMC), Manufacturing, & Commercialization-, Biotechnology, Biopharmaceuticals

Scott Burger

Scott Burger

Principal, Advanced Cell & Gene Therapy LLC

Jan Joseph Melenhorst

Jan Joseph Melenhorst

Adjunct Associate Professor, Upenn

John Rossi

John Rossi

Vice President, Head, Translational Medicine, , Syncopation Lifesciences

Devyn Smith

Devyn Smith

Chief Executive Officer, Arbor Biotechnologies

Hemant Dhamne

Hemant Dhamne

Head of Vector and CAR-T Cell Processing, Immuneel Therapeutics Pvt Ltd

Don Healey

Don Healey

SVP Operations and Site Head, KBI Pharma

Dominic Clarke

Dominic Clarke

Global Head Cell Therapy, Strategy and Innovation, , Charles River Laboratories

Xiaoxi Wei

Xiaoxi Wei

Founder & CEO, X-Therma Inc.

Patrick J. Hanley

Patrick J. Hanley

Director of GMP for Immunotherapy, The Children’s Research Institute

Bill Evans

Bill Evans

Process Chromatography Technical Specialist , Tosoh Bioscience LLC

Jayanthi Grebin

Jayanthi Grebin

Senior Business Development Manager, Cell & Gene Therapy , CPC

Margaret Temple

Margaret Temple

Business Development Manager, SGS

Steve Lock

Steve Lock

Marketing & Marketing Development Manager , SCIEX

Mahendra Rao

Mahendra Rao

Chief Executive Officer, panCella

Sarindr Bhumiratana

Sarindr Bhumiratana

Chief Scientific Officer , Epibone

Philip Ramsey

Philip Ramsey

Principal Lecturer , University of New Hampshire

Janet Rothberg

Janet Rothberg

Development Manager, CCRM

Amritha Jaishanker

Amritha Jaishanker

Associate Director, MD Stem Cell Research Fund , TEDCO

Fiona Bellot

Fiona Bellot

Protein Sales Manager, Proteintech

Gavin Allsop

Gavin Allsop

Senior Business Development Manager, OXGENE

SPONSORS